These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [The possibility of increasing the precision of biochemical diagnostics of Gaucher disease]. Horovenko NH; Drozdova VD; Nedoboĭ AM; Ol'khovych NV; Pichkur NO; Tsyhankova MA; Radzikhovs'ka OV Tsitol Genet; 2006; 40(3):67-71. PubMed ID: 16933855 [TBL] [Abstract][Full Text] [Related]
25. Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease. Czartoryska B; Tylki-Szymańska A; Lugowska A Clin Biochem; 2000 Mar; 33(2):147-9. PubMed ID: 10751594 [No Abstract] [Full Text] [Related]
26. Short-term effect of miglustat in every day clinical use in treatment-naïve or previously treated patients with type 1 Gaucher's disease. Giraldo P; Latre P; Alfonso P; Acedo A; Alonso D; Barez A; Corrales A; Franco R; Roldan V; Serrano S; Pocovi M Haematologica; 2006 May; 91(5):703-6. PubMed ID: 16627252 [TBL] [Abstract][Full Text] [Related]
27. Elevation of serum angiotensin-converting enzyme in Gaucher's disease. Lieberman J; Beutler E N Engl J Med; 1976 Jun; 294(26):1442-4. PubMed ID: 179000 [No Abstract] [Full Text] [Related]
29. Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: a case report of 24 months' oral substrate reduction therapy with miglustat. Hughes DA; Ginsberg L; Baker R; Goodwin S; Milligan A; Richfield L; Mehta AB Parkinsonism Relat Disord; 2007 Aug; 13(6):365-8. PubMed ID: 17049454 [TBL] [Abstract][Full Text] [Related]
30. Lysosomal enzyme activities in platelets of normal individuals and of patients with Gaucher's disease. Yatziv S; White M; Eldor A Thromb Diath Haemorrh; 1974 Dec; 32(2-3):665-9. PubMed ID: 4450208 [No Abstract] [Full Text] [Related]
31. [Comparison and clinical application of two methods for determination of plasma chitotriosidase activity]. Wang Y; Zhang HW; Ye J; Qiu WJ; Han LS; Gu XF Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):834-8. PubMed ID: 23302614 [TBL] [Abstract][Full Text] [Related]
33. The biology of the Gaucher cell: the cradle of human chitinases. Bussink AP; van Eijk M; Renkema GH; Aerts JM; Boot RG Int Rev Cytol; 2006; 252():71-128. PubMed ID: 16984816 [TBL] [Abstract][Full Text] [Related]
34. Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India. Sheth J; Pancholi D; Mistri M; Nath P; Ankleshwaria C; Bhavsar R; Puri R; Phadke S; Sheth F BMC Med Genet; 2018 Oct; 19(1):178. PubMed ID: 30285649 [TBL] [Abstract][Full Text] [Related]
35. Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease. Murugesan V; Liu J; Yang R; Lin H; Lischuk A; Pastores G; Zhang X; Chuang WL; Mistry PK Blood Cells Mol Dis; 2018 Feb; 68():47-53. PubMed ID: 28003098 [TBL] [Abstract][Full Text] [Related]
36. Variation in chitotriosidase values measured on simultaneous samples by two commercial laboratories. Sirrs S; Casey R; Patterson MA; McNeil C; Paquin W; Amato D Am J Hematol; 2013 Nov; 88(11):980. PubMed ID: 23861203 [No Abstract] [Full Text] [Related]
37. Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease. Schiffmann R; Heyes MP; Aerts JM; Dambrosia JM; Patterson MC; DeGraba T; Parker CC; Zirzow GC; Oliver K; Tedeschi G; Brady RO; Barton NW Ann Neurol; 1997 Oct; 42(4):613-21. PubMed ID: 9382473 [TBL] [Abstract][Full Text] [Related]
38. Accuracy of chitotriosidase activity and CCL18 concentration in assessing type I Gaucher disease severity. A systematic review with meta-analysis of individual participant data. Raskovalova T; Deegan PB; Mistry PK; Pavlova E; Yang R; Zimran A; Berger J; Bourgne C; Pereira B; Labarère J; Berger MG Haematologica; 2021 Feb; 106(2):437-445. PubMed ID: 32001533 [TBL] [Abstract][Full Text] [Related]
39. Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study. De Castro-Orós I; Irún P; Cebolla JJ; Rodriguez-Sureda V; Mallén M; Pueyo MJ; Mozas P; Dominguez C; Pocoví M; J Transl Med; 2017 Feb; 15(1):43. PubMed ID: 28222799 [TBL] [Abstract][Full Text] [Related]